| CASE REPORT |
|
| Year : 2022 | Volume
: 42
| Issue : 3 | Page : 134-137 |
|
|
Cellular immunotherapy with immune killer cells for treating a lung cancer patient with liver metastasis
Chieh-Yung Wang, Chung-Kan Peng, Chih-Feng Chian
Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
Correspondence Address:
Dr. Chih-Feng Chian
114 No. 325, Sec. 2, Cheng-Gong Road, Neihu 114, Taipei
Taiwan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jmedsci.jmedsci_384_20
|
|
|
Lung cancer has the highest number of deaths globally. About 75% of nonsmall cell lung cancer (NSCLC) cases are diagnosed at an advanced stage. Despite significant therapeutic progress, the prognosis remains poor. For patients who have undergone conventional treatment followed by disease progression, palliative care generally remains the only option. As reported in recent years, cellular immunotherapies play an important role in treating lung cancer and may be an option for terminal-stage disease. We applied a novel management approach with immune killer cells therapy to treat a patient with NSCLC with liver metastases. The carcinoembryonic antigen returned to normal level during the treatment period, and the follow-up abdominal computed tomography at 3 months after completion of the therapy displayed no residual metastatic liver tumors.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
